Comparison of 18F-MFBG and 68Ga-DOTATATE PET/CT in the Imaging of Metastatic Paraganglioma and Pheochromocytoma

被引:6
|
作者
Deng, Maoxue [1 ,2 ,3 ]
Shu, Qiaoqiao [1 ,2 ,3 ]
Hu, Mei [4 ]
Chen, Yue [1 ,2 ,3 ]
Cai, Liang [1 ,2 ,3 ]
机构
[1] Southwest Med Univ, Dept Nucl Med, Affiliated Hosp, 25 Taiping St, Luzhou 646000, Sichuan, Peoples R China
[2] Nucl Med & Mol Imaging Key Lab Sichuan Prov, Luzhou, Sichuan, Peoples R China
[3] Southwest Med Univ, Inst Nucl Med, Luzhou, Sichuan, Peoples R China
[4] Southwest Med Univ, Sch Pharm, Luzhou, Sichuan, Peoples R China
关键词
Ga-68-DOTATATE; F-18-MFBG; PET/CT; neuroendocrine; NOREPINEPHRINE TRANSPORTER;
D O I
10.1097/RLU.0000000000004314
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Two men with metastatic paraganglioma/pheochromocytoma underwent PET/CT examination in our hospital to understand the treatment effect and progression of the disease. Both patients had previously been treated with I-131-MIBG, and at this evaluation, both of them underwent Ga-68-DOTATATE and F-18-MFBG PET/CT. The Ga-68-DOTATATE PET/CT showed more metastases in the images of these 2 patients. This case highlighted that Ga-68-DOTATATE PET/CT is superior to F-18-MFBG PET/CT in detecting metastases from paraganglioma and pheochromocytoma in these 2 patients.
引用
收藏
页码:E735 / E737
页数:3
相关论文
共 50 条
  • [41] Squamous Cell Carcinoma Mimicking Neck Paraganglioma on 68Ga-DOTATATE PET/CT
    Civan, Caner
    Isik, Emine Goknur
    Has Simsek, Duygu
    Sen, Comert
    Unal, Seher Nilgun
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (07) : E368 - E370
  • [42] Somatostatin Receptor Imaging with 68Ga-DOTATATE PET/CT and its Comparison with 18F-FDG PET/CT in Patients with Estrogen Receptor Positive Metastatic Breast Cancer
    Chandekar, K.
    Satapathy, S.
    Dharmashaktu, Y.
    Ballal, S.
    Ranjan, P.
    Batra, A.
    Gogia, A.
    Mathur, S.
    Bal, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S484 - S484
  • [43] 68Ga-DOTATATE and 18F-FDG PET/CT in a Rapidly Progressing Lymphoma
    Parihar, Ashwin Singh
    Wahl, Richard L.
    Jahromi, Amin H.
    CLINICAL NUCLEAR MEDICINE, 2025, 50 (01) : e64 - e65
  • [44] Concurrent Metastatic Pheochromocytomas and Lung Adenocarcinoma on 18F-FDG and 68Ga-DOTATATE PET/CT Images
    Cheng, Zhaoting
    Zou, Sijuan
    Song, Shuang
    Zhu, Xiaohua
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (09) : 754 - 756
  • [45] Sporadic Primary Pheochromocytoma: A Prospective Intraindividual Comparison of Six Imaging Tests (CT, MRI, and PET/CT Using 68Ga-DOTATATE, FDG, 18F-FDOPA, and 18F-FDA)
    Jha, Abhishek
    Patel, Mayank
    Carrasquillo, Jorge A.
    Ling, Alexander
    Millo, Corina
    Saboury, Babak
    Chen, Clara C.
    Wakim, Paul
    Gonzales, Melissa K.
    Meuter, Leah
    Knue, Marianne
    Talvacchio, Sara
    Herscovitch, Peter
    Del Rivero, Jaydira
    Chen, Alice P.
    Nilubol, Naris
    Taieb, David
    Lin, Frank, I
    Civelek, Ali Cahid
    Pacak, Karel
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2022, 218 (02) : 342 - 350
  • [46] Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor
    Cheng, Zhaoting
    Zou, Sijuan
    Cheng, Siyuan
    Song, Shuang
    Zhu, Xiaohua
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (09) : 764 - 765
  • [47] Diagnostic Performance of 68 Ga-DOTATATE PET/CT, 18 F-FDG PET/CT and 131 I-MIBG Scintigraphy in Mapping Metastatic Pheochromocytoma and Paraganglioma
    Tan T.H.
    Hussein Z.
    Saad F.F.A.
    Shuaib I.L.
    Nuclear Medicine and Molecular Imaging, 2015, 49 (2) : 143 - 151
  • [48] 68Ga-DOTATATE PET/CT of Metastatic Lymphoepithelial Carcinoma of Parotid Gland
    Low, Han Chung
    Loke, Kelvin Siu Hoong
    Wang, Fu Qiang
    Han, Shuting
    Nei, Wen Long
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (12) : 1056 - 1058
  • [49] Incidental 68Ga-DOTATATE Uptake on PET/CT
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 (06) : 22N - 22N
  • [50] Osteoporosis Circumscripta on 68Ga-DOTATATE PET CT
    Gandy, Nemi
    Ordidge, Katherine Louise
    Arshad, Mubarik
    Win, Zarni
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (06) : E404 - E405